You are here: All Products  > Tigermed, a China Clinical CRO, Seeks up to $1 Billion in Hong Kong IPO

Tigermed, a China Clinical CRO, Seeks up to $1 Billion in Hong Kong IPO

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products